Gjølberg, Torleif Tollefsrud http://orcid.org/0000-0002-1719-7677
Wik, Jonas Aakre http://orcid.org/0000-0003-3065-5529
Johannessen, Hanna
Krüger, Stig
Bassi, Nicola
Christopoulos, Panagiotis F.
Bern, Malin
Foss, Stian
Petrovski, Goran
Moe, Morten C. http://orcid.org/0000-0002-0615-804X
Haraldsen, Guttorm
Fosse, Johanna Hol
Skålhegg, Bjørn Steen
Andersen, Jan Terje http://orcid.org/0000-0003-1710-1628
Sundlisæter, Eirik http://orcid.org/0009-0006-8046-8691
Funding for this research was provided by:
Norges Forskningsråd (314909)
Article History
Received: 8 March 2021
Accepted: 8 May 2023
First Online: 30 May 2023
Competing interests
: E.S. has received lecture fees from Allergan and consultancy fees from Sanofy Genzyme. M.C.M. has been a member of advisory boards at Bayer, Novartis, Roche and Allergan and has received lecture fees from Bayer and Roche. T.T.G. and J.T.A. have ownership interests in Authera AS. The remaining authors declare no competing interests.